Clene (CLNN) Current Leases (2019 - 2026)
Clene (CLNN) posted Current Leases of $815000.0 for Q2 2026, up 0.87% on a QoQ basis from $808000.0 in Q4 2025, and down 19.55% year-over-year from $1.0 million in Q2 2025.
Powered by 
Analysis
Clene (CLNN) Current Leases (2019 - 2026) Analysis & Trends
Clene has reported Current Leases for 8 years, with the latest figure at $815000.0 in Q2 2026.
- On a quarterly basis, Current Leases fell 19.55% year-over-year to $815000.0 in Q2 2026; TTM through Jun 2026 was $815000.0, a 19.55% decrease from a year earlier, with the FY2025 full-year figure at $808000.0, down 12.74% from the prior year.
- Current Leases was $815000.0 for Q2 2026 at Clene, up from $808000.0 in the prior quarter.
- The five-year high for Current Leases was $1.0 million in Q2 2025, with the low at $440000.0 in Q2 2022.
- Average Current Leases over 5 years is $665764.7, with a median of $599000.0 recorded in 2024.
- The sharpest annual moves came in 2022 and 2026: Current Leases surged 134.16% in 2022, then slipped 19.55% in 2026.
- Over 5 years, Current Leases stood at $488000.0 in 2022, then grew by 18.03% to $576000.0 in 2023, then soared by 60.76% to $926000.0 in 2024, then retreated by 12.74% to $808000.0 in 2025, then climbed by 0.87% to $815000.0 in 2026.
- The last three Current Leases figures came in at $815000.0 (Q2 2026), $808000.0 (Q4 2025), and $783000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | - |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | - |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | 274.00 Mn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | 263.86 Mn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | 16.75 Mn |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 4.26 Mn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | - |
| 10 | Clene | 45.69 Mn | 45.69 Mn | 54,000.00 | 815,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 815,000.00 |
| Dec 31, 2025 | 808,000.00 |
| Sep 30, 2025 | 783,000.00 |
| Jun 30, 2025 | 1.01 Mn |
| Mar 31, 2025 | 985,000.00 |
| Dec 31, 2024 | 926,000.00 |
| Sep 30, 2024 | 732,000.00 |
| Jun 30, 2024 | 623,000.00 |
| Mar 31, 2024 | 599,000.00 |
| Dec 31, 2023 | 576,000.00 |
| Sep 30, 2023 | 553,000.00 |
| Jun 30, 2023 | 529,000.00 |
| Mar 31, 2023 | 508,000.00 |
| Dec 31, 2022 | 488,000.00 |
| Sep 30, 2022 | 467,000.00 |
| Jun 30, 2022 | 440,000.00 |
| Mar 31, 2022 | 473,000.00 |
| Dec 31, 2021 | 347,000.00 |
| Sep 30, 2021 | 262,000.00 |
| Jun 30, 2021 | 210,000.00 |